| Sequential expression of miR‐182 and miR‐503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma L Li, AL Sarver, R Khatri, PB Hajeri, I Kamenev, AJ French, SN Thibodeau, ... The Journal of pathology 234 (4), 488-501, 2014 | 73 | 2014 |
| siRNAs: their potential as therapeutic agents–Part I. Designing of siRNAs PB Hajeri, SK Singh Drug discovery today 14 (17-18), 851-858, 2009 | 62 | 2009 |
| Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors DM Özata, X Li, L Lee, J Liu, D Warsito, P Hajeri, I Hultman, O Fotouhi, ... Cell Death & Disease 8 (5), e2759-e2759, 2017 | 59 | 2017 |
| siRNAs: their potential as therapeutic agents–Part II. Methods of delivery SK Singh, PB Hajeri Drug discovery today 14 (17-18), 859-865, 2009 | 43 | 2009 |
| CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer M Sato-Dahlman, Y Miura, JL Huang, P Hajeri, K Jacobsen, J Davydova, ... Oncotarget 8 (44), 76044, 2017 | 40 | 2017 |
| miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors WK Huang, P Akçakaya, A Gangaev, L Lee, K Zeljic, P Hajeri, E Berglund, ... Experimental cell research 371 (1), 287-296, 2018 | 35 | 2018 |
| Oncolytic adenoviruses: strategies for improved targeting and specificity PB Hajeri, NS Sharma, M Yamamoto Cancers 12 (6), 1504, 2020 | 23 | 2020 |
| Regulation of gene expression by small RNAs RK Gaur, JJ Rossi CRC Press, 2009 | 10 | 2009 |
| Molecular and cellular therapeutics D Whitehouse, R Rapley John Wiley & Sons, 2012 | 6 | 2012 |
| Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells H Yoshida, M Sato-Dahlman, P Hajeri, K Jacobsen, L Koodie, ... Translational oncology 14 (2), 100997, 2021 | 4 | 2021 |
| A novel method to generate high-sequence diversity libraries of plasmids and recombinant adenovirus based oncolytic viruses for targeted therapy MY Praveensingh B. Hajeri Molecular Therapy 28 (4S1), 158, 2020 | 1 | 2020 |
| RNA interference: from basics to therapeutics S Kumar Singh, PB Hajeri Molecular and Cellular Therapeutics, 140-167, 2012 | 1 | 2012 |
| Prostate-specific membrane antigen (PSMA)-binding peptides and method of use. MY Praveensingh B. Hajeri, Mizuho Dahlman US Patent App. U.S. Provisional Application No.: 63/547,517, 2023 | | 2023 |
| Systemic in Vivo Selection of Adenovirus and Infectivity Selective Adenoviruses Specific for PSMA Expressing Cells MY Praveensingh B. Hajeri, Mizuho Dahlman US Patent App. U.S. Provisional Application No.: 63/462,754, 2023 | | 2023 |
| Prostate-specific membrane antigen (PSMA)-binding peptides and method of use MY Praveensingh B. Hajeri, Mizuho Dahlman US Patent App. U.S. Provisional Application No.: 63/547,517, 2023 | | 2023 |
| Systemic in Vivo Selection of Adenovirus and Infectivity Selective Adenoviruses Specific for PSMA Expressing Cells. MY Praveensingh B. Hajeri, Mizuho Dahlman US Patent App. U.S. Provisional Application No.: 63/462,754, 2023 | | 2023 |
| Methods for producing a library of biological molecules PB Hajeri, M Yamamoto US Patent App. 17/616,521, 2022 | | 2022 |
| Characterization of the Cancer-Targeted Oncolytic Adenoviruses with Fiber-Knob Modification M Sato-Dahlman, P Hajeri, B Roach, S Shinoda, N Nakamura, ... MOLECULAR THERAPY 30 (4), 51-51, 2022 | | 2022 |
| Efficacy of Systemic Administration of Mesothelin-Targeted Oncolytic Adenovirus In Pancreatic Cancer M Sato-Dahlman, P Hajeri, K Jacobsen, C Yanagiba, M Yamamoto MOLECULAR THERAPY 29 (4), 322-323, 2021 | | 2021 |
| Methods for producing a library of biological molecules MY Praveensingh Bheemsingh Hajeri US Patent WO2020247735A1, 2020 | | 2020 |
